GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Immunogen, Inc. (IMGN) [hlAlert]

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The company's product candidates are called tumor-activated prodrugs and are
based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, tumor-activated prodrugs are intended to deliver potent chemotherapy specifically to a tumor. Each tumor-activated drug immunoconjugate comprises a small-molecule drug which has been chemically linked to a monoclonal antibody.
( Total: 19 Current Stock Recommendations )
Immunogen, Inc.   (19)
Hold 37% Buy 63%
Related companies
China Biologic ...   (4)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Flamel Technologies ...   (8)
Buy 100%
Aeterna Zentaris, ...   (12)
Buy 100%
Lannett Co Inc   (4)
Buy 100%
Anika Therapeutics ...   (4)
Buy 100%
Emergent ...   (6)
Buy 100%
Insys Therapeutics ...   (4)
Buy 100%
Show  

Date (ET)MemberRatingYTD
Gains
 
10/4/2007  
Buy
  
7/13/2009  
Hold
  
12/24/2009  
Buy
  
4/15/2010  
Buy
  
8/30/2010  
Buy
  
4/8/2011  
Buy
  
4/29/2011  
Buy
  
8/24/2012  
Hold
  
11/9/2012  
Hold
  
11/13/2012  
Hold
  
8/2/2013  
Buy
  
8/5/2013  
Hold
  
8/26/2013  
Buy
  
9/4/2013  
Buy
  
9/30/2013  
Buy
  
2/6/2015  
Buy
  
3/31/2015  
Hold
  
6/1/2015  
Buy
  
6/1/2015  
Hold
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy